nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP3A4—Methoxsalen—vitiligo	0.317	1	CbGbCtD
Sitaxentan—Sunburn—Methoxsalen—vitiligo	0.119	0.179	CcSEcCtD
Sitaxentan—Systemic lupus erythematosus—Methoxsalen—vitiligo	0.0651	0.0975	CcSEcCtD
Sitaxentan—Skin hyperpigmentation—Methoxsalen—vitiligo	0.0606	0.0908	CcSEcCtD
Sitaxentan—Herpes simplex—Methoxsalen—vitiligo	0.0391	0.0586	CcSEcCtD
Sitaxentan—Inflammation—Methoxsalen—vitiligo	0.0372	0.0557	CcSEcCtD
Sitaxentan—Skin exfoliation—Methoxsalen—vitiligo	0.0344	0.0515	CcSEcCtD
Sitaxentan—Dry skin—Methoxsalen—vitiligo	0.024	0.0359	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Methoxsalen—vitiligo	0.0207	0.0309	CcSEcCtD
Sitaxentan—Tension—Methoxsalen—vitiligo	0.0155	0.0232	CcSEcCtD
Sitaxentan—Nervousness—Methoxsalen—vitiligo	0.0153	0.0229	CcSEcCtD
Sitaxentan—Muscle spasms—Methoxsalen—vitiligo	0.0152	0.0227	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methoxsalen—vitiligo	0.0146	0.0219	CcSEcCtD
Sitaxentan—Malaise—Methoxsalen—vitiligo	0.0142	0.0213	CcSEcCtD
Sitaxentan—Vertigo—Methoxsalen—vitiligo	0.0142	0.0212	CcSEcCtD
Sitaxentan—Discomfort—Methoxsalen—vitiligo	0.0133	0.0199	CcSEcCtD
Sitaxentan—Oedema—Methoxsalen—vitiligo	0.0129	0.0193	CcSEcCtD
Sitaxentan—Infection—Methoxsalen—vitiligo	0.0128	0.0191	CcSEcCtD
Sitaxentan—Skin disorder—Methoxsalen—vitiligo	0.0125	0.0187	CcSEcCtD
Sitaxentan—Hypotension—Methoxsalen—vitiligo	0.012	0.018	CcSEcCtD
Sitaxentan—Insomnia—Methoxsalen—vitiligo	0.0116	0.0174	CcSEcCtD
Sitaxentan—Dyspepsia—Methoxsalen—vitiligo	0.0113	0.017	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methoxsalen—vitiligo	0.0111	0.0166	CcSEcCtD
Sitaxentan—Feeling abnormal—Methoxsalen—vitiligo	0.0106	0.0159	CcSEcCtD
Sitaxentan—Urticaria—Methoxsalen—vitiligo	0.0102	0.0153	CcSEcCtD
Sitaxentan—Body temperature increased—Methoxsalen—vitiligo	0.0102	0.0152	CcSEcCtD
Sitaxentan—Hypersensitivity—Methoxsalen—vitiligo	0.00948	0.0142	CcSEcCtD
Sitaxentan—Dizziness—Methoxsalen—vitiligo	0.00851	0.0127	CcSEcCtD
Sitaxentan—Rash—Methoxsalen—vitiligo	0.00811	0.0121	CcSEcCtD
Sitaxentan—Dermatitis—Methoxsalen—vitiligo	0.0081	0.0121	CcSEcCtD
Sitaxentan—Headache—Methoxsalen—vitiligo	0.00806	0.0121	CcSEcCtD
Sitaxentan—Nausea—Methoxsalen—vitiligo	0.00764	0.0114	CcSEcCtD
Sitaxentan—EDNRB—Peptide GPCRs—MC1R—vitiligo	0.00157	0.105	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide GPCRs—CCR6—vitiligo	0.00117	0.0783	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—MC1R—vitiligo	0.00112	0.0751	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide GPCRs—CCR6—vitiligo	0.00084	0.0561	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—MC1R—vitiligo	0.000739	0.0493	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000579	0.0386	CbGpPWpGaD
Sitaxentan—EDNRB—Peptide ligand-binding receptors—CCR6—vitiligo	0.000552	0.0368	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—MC1R—vitiligo	0.000529	0.0353	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000496	0.0331	CbGpPWpGaD
Sitaxentan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000463	0.0309	CbGpPWpGaD
Sitaxentan—EDNRB—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000432	0.0288	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000414	0.0276	CbGpPWpGaD
Sitaxentan—EDNRA—Peptide ligand-binding receptors—CCR6—vitiligo	0.000395	0.0264	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—MC1R—vitiligo	0.000378	0.0252	CbGpPWpGaD
Sitaxentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.00037	0.0247	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000355	0.0237	CbGpPWpGaD
Sitaxentan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000309	0.0206	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR ligand binding—CCR6—vitiligo	0.000282	0.0188	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—MC1R—vitiligo	0.00027	0.018	CbGpPWpGaD
Sitaxentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.000265	0.0177	CbGpPWpGaD
Sitaxentan—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.000218	0.0145	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—MC1R—vitiligo	0.000213	0.0142	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CCR6—vitiligo	0.000202	0.0135	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—MC1R—vitiligo	0.000194	0.0129	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CCR6—vitiligo	0.000159	0.0106	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—MC1R—vitiligo	0.000153	0.0102	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCR6—vitiligo	0.000145	0.00966	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MC1R—vitiligo	0.000139	0.00925	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MC1R—vitiligo	0.000114	0.00764	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR6—vitiligo	0.000114	0.00761	CbGpPWpGaD
Sitaxentan—CYP3A4—Tryptophan metabolism—CAT—vitiligo	0.000109	0.00726	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCR6—vitiligo	0.000104	0.00691	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTT1—vitiligo	9.34e-05	0.00623	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR6—vitiligo	8.55e-05	0.00571	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTT1—vitiligo	8.52e-05	0.00568	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2RA—vitiligo	8.37e-05	0.00559	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MC1R—vitiligo	8.19e-05	0.00547	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SH2B3—vitiligo	8.1e-05	0.00541	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—GZMB—vitiligo	8.05e-05	0.00538	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL2RA—vitiligo	7.6e-05	0.00507	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR6—vitiligo	6.12e-05	0.00408	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2RA—vitiligo	5.99e-05	0.004	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTM1—vitiligo	5.95e-05	0.00397	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTM1—vitiligo	5.87e-05	0.00392	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SH2B3—vitiligo	5.8e-05	0.00387	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—GZMB—vitiligo	5.76e-05	0.00385	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTT1—vitiligo	5.62e-05	0.00375	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL2RA—vitiligo	5.44e-05	0.00363	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTM1—vitiligo	5.43e-05	0.00362	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTM1—vitiligo	5.35e-05	0.00357	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2RA—vitiligo	4.49e-05	0.003	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CD80—vitiligo	3.75e-05	0.0025	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTM1—vitiligo	3.58e-05	0.00239	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	3.53e-05	0.00236	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RA—vitiligo	3.21e-05	0.00214	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CD80—vitiligo	2.68e-05	0.00179	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—vitiligo	1.6e-05	0.00107	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—vitiligo	1.46e-05	0.000972	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CD44—vitiligo	1.33e-05	0.000886	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CD44—vitiligo	1.21e-05	0.000808	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—vitiligo	1.08e-05	0.000719	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—vitiligo	1.02e-05	0.000679	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—vitiligo	9.82e-06	0.000656	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—vitiligo	9.61e-06	0.000641	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—vitiligo	9.28e-06	0.000619	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CD44—vitiligo	7.98e-06	0.000533	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—vitiligo	6.48e-06	0.000432	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—vitiligo	6.12e-06	0.000408	CbGpPWpGaD
